1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) Avelina Martinez arrived at facility unannounced to conduct a case management visit on August 10, 2023 at 10:15 AM. LPA Martinez met with Gloria Dulay and explained the purpose of the visit.
The purpose of the visit today, is in response to a learned deficiency during complaint investigation 27-AS-20230804152452. As of August 04, 2023, staff administered R1 Escitalopram 5MG take 1 tablet by mouth daily for 14 days then stop. However, R1's Medication Administration Record (MAR) states, "Take 2 tablets by mouth at bed time". The facility did not update R1's MAR to reflect Escitalopram medication change. As a result, the facility did not maintain R1' medication record.
The following deficiency was observed and cited from the California Code of Regulations, Title 22, and California Health and Safety Code.
An exit interview was conducted, and a 809 report, 809-D page, and appeal rights were given to the facility.
|